Nuvalent Inc (NUVL)

Nuvalent Inc (NUVL) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Jul 17, 2026: market cap $9.8B; returns 1 week +0.0%, 1 year +44.7%.

Nuvalent, Inc. is a clinical-stage biopharmaceutical company specializing in the development of precisely targeted, small molecule therapies for patients with cancer. The company's core business model is centered on its research and development pipeline and does not currently generate revenue from product sales.

NUVL financial model: income statement, cash flow and balance sheet